iPass (IPAS), Uber to Provide International Uber Riders With Free Wi-Fi Access in Rio de Janeiro
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
iPass Inc. (NASDAQ: IPAS), the leading provider of global mobile connectivity, and Uber today announced a partnership to provide international Uber riders with free Wi-Fi in Rio de Janeiro. As part of the partnership, iPass will provide Uber riders with access to more than 1350 iPass commercial hotspots in Rio de Janeiro. Starting immediately, the promotion will run until August 21.
Within the Brazilian city, iPass boasts a notable footprint, with Wi-Fi coverage in elite hotels, in tourist-friendly neighborhoods, Copacabana and Ipanema, and near popular sporting venues.
"Mobility is a major challenge during an event of this magnitude," said Gui Telles, General Manager of Uber in Brazil. "To help Uber riders have a seamless experience, we are partnering with iPass to provide access to Wi-Fi all around Rio."
"We are extremely excited to be working with Uber to provide Wi-Fi access to its international rider base in Rio," said Gary Griffiths, president and CEO of iPass. "Like Uber, iPass is in the business of connecting people. And therefore, we see this as a natural partnership."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY), Ono Enter Settlement and License Agreement with Merck (MRK) to Resolve PD-1 Antibody Patent Litigation
- PG&E Submits $250M Proposal in Support of Electric Vehicles in California (PCG)
- Minerva Neurosciences (NERV) Reports Additional Data Analyses From Phase IIb Trial of MIN-101 in Schizophrenia
Create E-mail Alert Related CategoriesCorporate News, General News, Management Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!